An Act to make provision in connection with controlling the cost of health service medicines and other medical supplies; to make provision in connection with the provision of pricing and other information by those manufacturing, distributing or supplying those medicines and supplies, and other related products, and the disclosure of that information; and for connected purposes.
It provides that pharmaceutical companies can be compelled to reduce the price of a generic medicine or introduce other controls on branded products in cases where charges are “unreasonable”.[1]
